Table 4 Previous diagnosis and treatment before an IPF diagnosis was made
From: Risk factors for diagnostic delay in idiopathic pulmonary fibrosis
All patients (n = 204) | |
|---|---|
Alternative diagnoses for respiratory symptoms | |
Heart disease | 25 (12.3%) |
Asthma | 17 (8.3%) |
Chronic bronchitis | 11 (5.4%) |
COPD | 10 (4.9%) |
Emphysema | 3 (1.5%) |
Other | 18 (8.8%) |
Reports of pneumonia during the previous 2 years before IPF diagnosis | |
0 | 88 (49.2%) |
1 | 32 (17.9%) |
2 | 28 (15.6%) |
3 or more | 31 (18.0%) |
Antibiotic courses for pneumonia during the previous 2 years before IPF diagnosis | |
0 | 91 (50.6%) |
1 | 35 (19.4%) |
2 | 31 (17.2%) |
3 or more | 23 (11.3%) |
Previous medical treatments | |
Inhalation therapy | |
SABA | 39 (19.1%) |
LABA | 29 (14.2%) |
LAMA | 21 (10.3%) |
ICS | 26 (12.7%) |
Prednisolone | 34 (16.7%) |
Other immunosuppressive treatmenta | 5 (2.5%) |
Proton pump inhibitor or H2-receptor antagonist | 85 (41.7%) |
Antacids | 57 (31.7%) |